Mei X, Sweatt A J, Hammarback J A
Department of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
J Neurosci Res. 2000 Oct 1;62(1):56-64. doi: 10.1002/1097-4547(20001001)62:1<56::AID-JNR6>3.0.CO;2-#.
The MAP1B and MAP1A genes each produce an mRNA that encodes a polyprotein. When cleaved, each polyprotein yields a single heavy chain and a single light chain, which become noncovalently associated. In previous work, it was found that the MAP1B light chains and heavy chains exist in a 2:1 ratio. Through use of quantitative immunoblot techniques, this finding was further examined in the developing rat brain. MAP1B heavy chain (HC) and light chain (LC1), as well as the light chain of MAP1A (LC2), were prepared in purified form for use as standards and/or immunogens for generation of antibodies for immunoblotting. Brain homogenates and microtubule-enriched fractions from developing rats were assayed for MAP1B HC and LC1 content. Results indicated that postnatal rat brain homogenates contain LC1 in a 6:1 to 8:1 molar ratio to the MAP1B HC. Purified microtubules also contain LC1 in excess of MAP1B HC, but at a ratio of 2:1. We propose that most of the excess LC1 in homogenates is either insoluble or not bound to microtubules. The findings raise the possibility of a function for the "excess" LC1 that does not require association with MAP1 HC and/or microtubules. Given a synthetic mechanism that produces MAP1B HC and LC1 in a 1:1 ratio at both transcription and translation steps, we propose that the "excess" LC1 in brain homogenates is a consequence of LC1 having a greater half-life than the MAP1B HC. Consistently with this hypothesis, a major pool of MAP1B HC is rapidly degraded after blocking protein synthesis with cycloheximide, whereas LC1 levels remain constant even after 24 hr of cycloheximide treatment.
MAP1B和MAP1A基因各自产生一种编码多聚蛋白的mRNA。裂解后,每种多聚蛋白产生一条重链和一条轻链,它们通过非共价结合。在之前的研究中,发现MAP1B轻链和重链的存在比例为2:1。通过定量免疫印迹技术,在发育中的大鼠大脑中进一步研究了这一发现。制备了纯化形式的MAP1B重链(HC)、轻链(LC1)以及MAP1A轻链(LC2),用作标准品和/或免疫原,以生成用于免疫印迹的抗体。检测了发育中大鼠的脑匀浆和富含微管的组分中MAP1B HC和LC1的含量。结果表明,出生后大鼠脑匀浆中LC1与MAP1B HC的摩尔比为6:1至8:1。纯化的微管中LC1也过量于MAP1B HC,但比例为2:1。我们推测,匀浆中大部分过量的LC1要么不溶,要么未与微管结合。这些发现增加了“过量”LC1存在一种不需要与MAP1 HC和/或微管结合的功能的可能性。鉴于在转录和翻译步骤中以1:1比例产生MAP1B HC和LC1的合成机制,我们推测脑匀浆中“过量”的LC1是由于LC1的半衰期比MAP1B HC长。与这一假设一致的是,在用环己酰亚胺阻断蛋白质合成后,MAP1B HC的主要池迅速降解,而即使在环己酰亚胺处理24小时后,LC1水平仍保持不变。